SCHEMBL14908602

SCHEMBL14908602

Cc1cc(C)nc(Nc2nc(NCCN)c(F)cc2C(N)=O)c1

nearest known ligand 0.49

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
SYK P43405 18/20 0.49
ZAP70 P43403 4/20 0.43
KCNH2 Q12809 5/20 0.43
AURKB Q96GD4 1/20 0.43
CD38 P28907 1/20 0.38
CAMK1D Q8IU85 1/20 0.37
LCK P06239 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14909820 0.86 SYK (0.65) SYKZAP70KCNH2AURKBCAMK1D
SCHEMBL14910084 0.85 SYK (0.52) SYKZAP70KCNH2AURKBCD38
SCHEMBL14923793 0.81 SYK (0.65) SYKZAP70KCNH2AURKBCAMK1D
SCHEMBL14923870 0.79 SYK (0.69) SYKZAP70KCNH2AURKBCAMK1D
SCHEMBL14929435 0.78 SYK (0.56) SYKZAP70KCNH2AURKBCAMK1D
SCHEMBL14929769 0.78 SYK (0.56) SYKZAP70KCNH2AURKB
SCHEMBL14923857 0.77 SYK (0.66) SYKZAP70KCNH2AURKBCD38
SCHEMBL14911272 0.76 SYK (0.47) SYKZAP70KCNH2AURKBCAMK1D
SCHEMBL14910223 0.76 NPC1 (0.44) SYKZAP70KCNH2AURKBCAMK1D
SCHEMBL14909873 0.75 SYK (0.50) SYKZAP70KCNH2AURKBCAMK1D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2589592-B1 NOVEL NICOTINAMIDE DERIVATIVES OR SALTS THEREOF FUJIFILM CORP (JP) 2018-08-22 EP disclosed
US-8895585-B2 Nicotinamide derivative or salt thereof FUJIFILM CORPORATION (JP) 2014-11-25 US disclosed
US-8895585-B2 Nicotinamide derivative or salt thereof FUJIFILM CORPORATION (JP) 2014-11-25 US disclosed
US-8895585-B2 Nicotinamide derivative or salt thereof FUJIFILM CORPORATION (JP) 2014-11-25 US disclosed
US-8809371-B2 2014-08-19 US disclosed
US-8809371-B2 2014-08-19 US disclosed
US-8809371-B2 2014-08-19 US disclosed
US-8772320-B2 2014-07-08 US disclosed
US-20130116430-A1 NOVEL NICOTINAMIDE DERIVATIVE OR SALT THEREOF FUJIFILM CORPORATION (JP) 2013-05-09 US disclosed
US-20130116430-A1 NOVEL NICOTINAMIDE DERIVATIVE OR SALT THEREOF FUJIFILM CORPORATION (JP) 2013-05-09 US disclosed
US-20130116430-A1 NOVEL NICOTINAMIDE DERIVATIVE OR SALT THEREOF FUJIFILM CORPORATION (JP) 2013-05-09 US disclosed
EP-2589592-A1 NOVEL NICOTINAMIDE DERIVATIVES OR SALTS THEREOF FUJIFILM Corporation (JP) 2013-05-08 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130116430-A1 NOVEL NICOTINAMIDE DERIVATIVE OR SALT THEREOF SYK, CD38, BTK SYK 1/4885ZAP70 183/4885KCNH2 1263/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.